Coronavirus
223
7
8
134
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
43 trials with published results (19%)
Research Maturity
134 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.9%
22 terminated out of 223 trials
85.9%
-0.6% vs benchmark
14%
31 trials in Phase 3/4
32%
43 of 134 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 134 completed trials
Clinical Trials (223)
SPI-1005 Treatment in Severe COVID-19 Patients
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2
COVID-19 Biorepository
Rutgers COVID-19 Cohort Study
A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
An Observational Study of Patients With Coronavirus Disease 2019
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
A Study of a Candidate COVID-19 Vaccine (COV001)
Investigating a Vaccine Against COVID-19
Antibody Detection of Vaccine-Induced Secretory Effects